Catherine S Diefenbach, MD¹, Opeyemi Jegede^2*, Stephen M Ansell, MD, PhD³, Christian Steidl, MD, PhD⁴, Yasodha Natkunam, MD, PhD^5,6, David W. Scott, MBChB, PhD⁷, Neha Mehta-Shah, MD⁸, Jennifer E Amengual, MD^9*, Christopher J. Forlenza, MD¹⁰, Peter D. Cole, MD¹¹, Nancy L. Bartlett, MD¹², Kevin A. David, MD^13*, Ranjana H. Advani, MD¹⁴, Richard F. Ambinder, MD¹⁵, Sachdev Thomas, MD¹⁶, Sami Ibrahimi, MD^17* and Brad S. Kahl, MD¹⁸

¹Perlmutter Cancer Center at NYU Langone Health, New York, NY
²CIMAC-CIDC Network, Department of Data Science, Boston, MA
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁵Department of Pathology, Stanford University School of Medicine, Stanford, CA
⁶Stanford Univ. Med. Ctr., Stanford, CA
⁷Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
⁸Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁹Lymphoma Program, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York
¹⁰Memorial Sloan Kettering Cancer Center, West Harrison, NY
¹¹Rutgers Ca Inst of NJ - Rbt Wood Johnson Univ Hosp, New Brunswick, NJ
¹²Siteman, Washington University School of Medicine, St Louis, MO
¹³Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ
¹⁴Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
¹⁵Johns Hopkins University School of Medicine, Baltimore, MD
¹⁶VA CENTRAL CALIFORNIA HEALTH CARE SYSTEM, FRESNO, CA
¹⁷University of Oklahoma Health Sciences Center, Oklahoma City, OK
¹⁸Washington University School of Medicine in St. Louis, Saint Louis, MO

Hun Ju Lee, MD^1*, Ian W. Flinn, MD, PhD², Jason Melear, MD³, Rod Ramchandren, MD⁴, Judah Friedman, MD^5*, John M. Burke, MD⁶, Yuliya Linhares, MD⁷, Paul Alan Gonzales, MD^8*, Mihir Raval, MD⁹, Rangaswamy Chintapatla, MD¹⁰, Tatyana Feldman, MD¹¹, Habte A. Yimer, MD¹², Miguel Islas-Ohlmayer, MD¹³, Asad Dean^9*, Vishal Rana, MD^14*, Mitul Gandhi, MD¹⁵, John Scott Renshaw, MD¹⁶, Linda Ho, MD^17*, Michelle A. Fanale, MD^17*, Wenchuan Guo, PhD^17* and Chris Yasenchak^18*

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN
³Texas Oncology, Austin, TX
⁴Karmanos Cancer Institute, Knoxville, TN
⁵Florida Cancer Specialists & Research Institute, Palm Springs, FL
⁶Rocky Mountain Cancer Centers, US Oncology Research, Aurora, CO
⁷Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health South Florida, Miami, FL
⁸Brook Army Medical Center at Fort Sam, Houston, TX
⁹US Oncology Research, The Woodlands, TX
¹⁰Kadlec Clinic, Kennewick, WA
¹¹John Theurer Cancer Center, Hackensack, NJ
¹²Texas Oncology-Tyler/US Oncology Research, Tyler, TX
¹³Oncology Hematology Care, Cincinnati, OH
¹⁴University of Colorado Health Hematology and Oncology, Colorado Springs, CO
¹⁵US Oncology Site - Virginia Cancer Specialists, Fairfax, VA
¹⁶Texas Oncology, San Antonio, TX
¹⁷Seagen Inc., Bothell, WA
¹⁸US Oncology Research, Willamette Valley Cancer Institute and Research Center, Eugene, OR

Keshu Zhou, MD^1*, Yuqin Song, MD², Tienan Yi^3*, Shuling Hou^4*, Xingchen Liu^5*, Ningjing Lin^6*, Tingting Du^6*, Xing Zhao^3*, Xiaobo Wu^4*, Xiwen Zhao^7*, Wei Meng^7*, Wencheng Xu^7*, Qiying Lu^7*, Wenzhi Tian^7* and Jun Zhu, MD^8*

¹Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
²Peking University Cancer Hospital and Institute, Beijing, China
³Oncology Department, Xiangyang Central Hospital Hubei University of Art and Science, Xiangyang, China
⁴Department of Lymphatic Oncology, Shanxi Bethune Hospital, Taiyuan, China
⁵Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁶Department of Lymphatic Oncology, Beijing Cancer Hospital, Beijing, China
⁷ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China
⁸Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China

Sharon M. Castellino, MD, MSc^1,2, Hongli Li, MS^3*, Alex F. Herrera, MD⁴, Angela Punnett, MD^5*, Michael Leblanc^3*, Susan K Parsons, MD, MRCP⁶, David Hodgson, MD^7,8*, Frank Keller, MD^9,10*, Richard A. Drachtman, MD¹¹, Adam Lamble, MD^12*, Christopher J. Forlenza, MD¹³, Andrew Doan, MD^14*, Sarah C. Rutherford, MD¹⁵, Andrew M Evens, DO, MBA, MMSc^16,17, Richard F. Little, MD, MPH¹⁸, Malcolm A. Smith, MD, PhD^19*, Joo Y Song, MD²⁰, Sonali M. Smith²¹, Jonathan W. Friedberg, MD, MMSc²² and Kara M. Kelly, MD²³

¹Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
²Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
³Fred Hutchinson Cancer Center, Seattle, WA
⁴City of Hope, Duarte, CA
⁵The hospital for sick children, Toronto, ON, Canada
⁶The Center for Health Solutions, Tufts Medical Center, Boston, MA
⁷Toronto, Toronto, ON, CAN
⁸Princess Margaret Hospital, Toronto, ON, CAN
⁹Aflac Cancer Ctr. & Blood Disorders Svc., Atlanta, GA
¹⁰Department of Pediatrics, Emory University, Atlanta
¹¹Rutgers Cancer Institute New Jersey, New Brunswick, NJ
¹²Seattle Children's - Hematology-Oncology, Seattle, WA
¹³Memorial Sloan Kettering Cancer Center, West Harrison, NY
¹⁴Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, CA
¹⁵Weill Cornell Medicine, New York, NY
¹⁶NJ, Warren, NJ
¹⁷Division of Blood Disorders, Rutgers Cancer Institute New Jersey, New Brunswick, NJ
¹⁸Division of Cancer Prevention, National Cancer Institute, Washington, DC
¹⁹National Institutes of Health, Bethesda, MD
²⁰City of Hope National Medical Center, Duarte, CA
²¹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²²Wilmot Cancer Center, University of Rochester, Rochester, NY
²³Roswell Park Comprehensive Cancer Center, Buffalo, NY

Jeremy S. Abramson, MD¹, David J. Straus, MD², Nancy L. Bartlett, MD^3*, John M. Burke, MD⁴, Ryan C Lynch, MD⁵, Eva Domingo Domenech, MD^6*, Brian Hess, MD⁷, Steven R. Schuster, MD⁸, Yuliya Linhares, MD⁹, Rod Ramchandren, MD^10*, Mitul Gandhi, MD¹¹, Rex Mowat, MD^12*, Harsh Shah, DO^13*, Wojciech Jurczak, MD, PhD¹⁴, Alessandro Re, MD^15*, Uwe Hahn, MD^16*, H. Miles Prince, MD¹⁷, Wenchuan Guo, PhD^18*, Linda Ho, MD^18*, Rose C. Beck, MD, PhD¹⁸, Christopher A. Yasenchak, MD^19* and Hun Ju Lee, MD^20*

¹Massachusetts General Hospital, Boston, MA
²Memorial Sloan Kettering Cancer Center, New York, NY
³Washington University School of Medicine, St. Louis, MO
⁴Rocky Mountain Cancer Centers, US Oncology Research, Aurora, CO
⁵Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
⁶Hospital Duran i Reynals, Institut Catalá d'Oncologia, Barcelona, Spain
⁷Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁸UCHealth Poudre Valley Hospital, Fort Collins, CO
⁹Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health South Florida, Miami, FL
¹⁰University of Tennessee Medical Center, Knoxville
¹¹US Oncology Site - Virginia Cancer Specialists, Fairfax, VA
¹²Toledo Clinic Cancer Centers, Toledo, OH
¹³Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁴Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
¹⁵UC Hematology, ASST Spedali Civili di Brescia, Brescia BS, Italy
¹⁶Royal Adelaide Hospital, Adelaide SA, Australia
¹⁷Epworth Freemasons, Melbourne VIC, Australia
¹⁸Seagen Inc., Bothell, WA
¹⁹US Oncology Research, Willamette Valley Cancer Institute and Research Center, Eugene, OR
²⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Elizabeth H Phillips^1*, Amy A Kirkwood^2*, Christina Hague^3*, Jorgen Vestbo^4*, Massimo Federico, MD⁵, Francesco D'Amore^6*, Alexander Fossa, MD^7*, Judith Trotman, MBChB, FRACP, FRCPA⁸, Leanne Berkahn, MD⁹, Daniel L. Molin, MD^10*, Stefano Luminari^11*, Sally F Barrington, MD^12*, Peter Johnson, MD, FRCP^13* and John Radford, MD^14*

¹Division of Cancer Sciences, University of Manchester, University of Manchester, Manchester, United Kingdom
²Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom
³Department of Clinical Oncology, The Christie Hospital NHS Trust, Manchester, United Kingdom
⁴Division of Immunology, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom
⁵Oncologia Medica, University of Modena and Reggio Emilia, Modena, Italy
⁶Department of Hematology,, Aarhus University Hospital, Aarhus, Denmark
⁷Department of Oncology, Oslo University Hospital, Oslo, Norway
⁸Concord Repatriation General Hospital, University of Sydney, and Australasian Leukaemia and Lymphoma Group, Sydney, Australia
⁹Haematology Department, Auckland City Hospital, and Australasian Leukaemia and Lymphoma Group, Auckland, New Zealand
¹⁰Oncology Department, Uppsala University, Uppsala, Sweden
¹¹Hematology Department, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy
¹²School of Biomedical Engineering and Imaging Sciences, King's College London and Guy's and St Thomas' PET Centre, London, United Kingdom
¹³School of Cancer Sciences, University of Southampton, Southampton, United Kingdom
¹⁴Division of Cancer Sciences, University of Manchester, NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom